Zhengye Biotechnology Holding Ltd - ZYBT

Sector: Healthcare · Industry: Pharmaceutical Preparations
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q4 2025 · Q3 2025
Value (USD)
Total reported value ($000)
$260K
QoQ value delta ($000)
-$152K (-36.89%)
Implied price effect (QoQ)
-56.57%
Shares
Total shares
230,686
QoQ shares delta
+71,943 (+45.32%)
Total shares held by funds (by quarter)
Shares (left)

Fund holders include prior positions carried forward until a new 13F confirms a change. Reported holders have reported a position in this security for that quarter; this is not the total number of 13F filers.

Market chart (ZYBT)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q4 2025)

Top 25 only Full list
Early Q2 2026 data: only 8 institutional holders reported so far. More will appear as funds file with the SEC.
Manager Value ($000) Shares % of 13F
WINTON GROUP Ltd 72 63,297 0.0%
XTX Topco Ltd 68 59,286 0.0%
Invesco Ltd. 39 34,688 0.0%
CITADEL ADVISORS LLC 35 30,576 0.0%
GEODE CAPITAL MANAGEMENT, LLC 33 29,068 0.0%
UBS Group AG 10 9,115 0.0%
Tower Research Capital LLC (TRC) 2 2,207 0.0%
MORGAN STANLEY 1 1,607 0.0%
JPMORGAN CHASE & CO 0 457 0.0%
ROYAL BANK OF CANADA 0 383 0.0%
Caitong International Asset Management Co., Ltd 0 2 0.0%